Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 126 - 150 of 2,573

«
1
…
4
5
6
7
8
…
103
»

Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy

Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy

By: Sajeel Chowdhary, MD

Immunotherapy in Metastatic Breast Cancer

Immunotherapy in Metastatic Breast Cancer

By: Alberto Montero, MD

Immunotherapy in Metastatic Breast Cancer

Immunotherapy in Metastatic Breast Cancer

By: Alberto Montero, MD

How I treat HER2+ Breast Cancer in 2023

How I treat HER2+ Breast Cancer in 2023

By: Alberto Montero, MD

Hormonal Therapy in Breast Cancer

Hormonal Therapy in Breast Cancer

By: Alberto Montero, MD, MBA, CPHQ

Immunotherapy in Breast

Immunotherapy in Breast

By: Alberto Montero, MD, MBA, CPHQ

Immunotherapy in Breast

Immunotherapy in Breast

By: Alberto Montero, MD, MBA, CPHQ

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

By: Alberto Montero, MD, MBA, CPHQ

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

By: Alberto Montero, MD, MBA, CPHQ

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Anthony Elias, MD

Triple Negative Breast Cancer

Triple Negative Breast Cancer

By: Anthony Elias, MD

Immunotherapy for Breast

Immunotherapy for Breast

By: Aurelio B. Castrellon, MD

How Do I Treat Stage IV TNBC

How Do I Treat Stage IV TNBC

By: Aurelio Castrellon, MD

Immunotherapy in Breast Cancer: Now & The Future

Immunotherapy in Breast Cancer: Now & The Future

By: Avan Armaghani, MD

HER2-Positive Breast Cancer Updates

HER2-Positive Breast Cancer Updates

By: Bora Lim, MD

HER2-Positive Breast Cancer Updates

HER2-Positive Breast Cancer Updates

By: Bora Lim, MD

Treatment of Early-Stage HER2+ Breast Cancer

Treatment of Early-Stage HER2+ Breast Cancer

By: Chau T. Dang, MD

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

By: Constanza Guaqueta, MD

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

By: Constanza Guaqueta, MD

Predictive and Prognostic BiomarkersUsing Genomic Profile in Adjuvant Breast Cancer

By: D. Constanza Guaqueta, MD

Parp Inhibitors and Chemotherapy for Breast Cancer

Parp Inhibitors and Chemotherapy for Breast Cancer

By: D. Constanza Guaqueta, MD

Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise

Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise

By: Daniel F. Hayes, MD

Late Recurrences in ER Positive Breast Cancer: The Next Frontier?

Late Recurrences in ER Positive Breast Cancer: The Next Frontier?

By: Daniel F. Hayes, MD

Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise

Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise

By: Daniel F. Hayes, MD

Late Recurrences in ER Positive Breast Cancer: The Next Frontier?

Late Recurrences in ER Positive Breast Cancer: The Next Frontier?

By: Daniel F. Hayes, MD

«
1
…
4
5
6
7
8
…
103
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok